POSTRE<\/a><\/p>\n<\/div>\n<\/div>\n\n\n\n
\n\n\n\nSTREDA 2.10.2019<\/h2>\n\n\n\n
\n\n\n\n
15,00 \u2013 15,30 Sl\u00e1vnostn\u00e9 otvorenie<\/strong>
Sl\u00e1vnostn\u00e9 uvedenie novej knihy do \u017eivota:
O\u010dkovanie v \u0161peci\u00e1lnych situ\u00e1ci\u00e1ch od autorsk\u00e9ho kolekt\u00edvu Milo\u0161 Jese\u0148\u00e1k, Ingrid Urban\u010d\u00edkov\u00e1 a kol. pod z\u00e1\u0161titou SSAKI a \u010cSAKI
<\/p>\n\n\n\n15,30 – 18,00 \u00davodn\u00e9 symp\u00f3zium<\/strong><\/p>\n\n\n\n- M. Smie\u0161ko (Bazilej, CH): Racion\u00e1lny dizajn E-selekt\u00edvnych antagonistov <\/li>
- M. Hrubi\u0161ko (Bratislava, SR): Sme pripraven\u00ed na zmeny \u017eivotn\u00e9ho prostredia?<\/li>
- P. Pru\u017einec (Bratislava, SR): Alergia \u2013 star\u00fd pes a nov\u00e9 k\u00fasky<\/li>
- P. Panzner (Plze\u0148, \u010cR): Frekvence a v\u00fdznam sensibilizac\u00ed k inhala\u010dn\u00edm perenialn\u00edm komponent\u00e1m<\/li>
- D. Stanekov\u00e1 (Bratislava, SR): Quo vadis prevencia HIV \/AIDS?<\/li><\/ol>\n\n\n\n
\n\n\n\n\u0160TVRTOK 3.10.2019<\/h2>\n\n\n\n
\n\n\n\n\n
\n
S\u00e1la A
8,00 \u2013 9,55 Imunodeficiencie
Predsedn\u00edctvo: P. \u010ci\u017en\u00e1r, M. Jese\u0148\u00e1k<\/strong><\/h2>\n\n\n\n- T. Milota et al. (Praha, Hradec Kr\u00e1lov\u00e9, \u010cR): Prim\u00e1rn\u00ed imunodeficience a malignity <\/li>
- M. Jese\u0148\u00e1k et al. (Martin, SR): PID spojen\u00e9 s erytrodermiou <\/li>
- V. Urdov\u00e1 (Bratislava, SR ): \u0164a\u017ek\u00fd kombinovan\u00fd imunodeficit <\/li>
- J. Strakov\u00e1 (Martin, SR): Lymfadenopatia, splenomeg\u00e1lia, granul\u00f3my \u2013 autoimunita , infekcia, malignita alebo PID ? (kazuistiky) <\/li>
- P. \u010ci\u017en\u00e1r (Bratislava, SR): DADA2 deficit <\/li>
- J. Hanzl\u00edkov\u00e1 (Plze\u0148, \u010cesko): Z\u00e1chyt hyperIgD<\/li>
- N. Luk\u00e1n et al (Ko\u0161ice, Bratislava, SR): Multicentrick\u00e9 klinick\u00e9 sledovanie v\u00fdskytu infekci\u00ed u pacientiek s diagn\u00f3zou karcin\u00f3m prsn\u00edka \u2013 predbe\u017en\u00e9 v\u00fdsledky <\/li><\/ol>\n\n\n\n
10.00 \u2013 11.00 Lie\u010dime pacientov spr\u00e1vne?
Predsedn\u00edctvo: P. Pru\u017einec, M. Jese\u0148\u00e1k<\/strong><\/h2>\n\n\n\n- P. Pru\u017einec (Bratislava, SR): Kontrola sympt\u00f3mov<\/li>
- M. Jese\u0148\u00e1k (Martin, SR): 13. komnata alergickej rinit\u00eddy<\/li>
- K. Koss\u00e1rov\u00e1 (Bratislava, SR): St\u00e1le nebudeme o\u010dkova\u0165 proti chripke?
Symp\u00f3zium podporen\u00e9 spolo\u010dnos\u0165ou Mylan<\/li><\/ol>\n\n\n\n11.05\u2013 12.05 \u00daskalia a n\u00e1strahy rozhodovania v ka\u017edodennej praxi imunoalergol\u00f3ga
Predsedn\u00edctvo: M. Hrubi\u0161ko, M. Schvalbov\u00e1<\/strong><\/h2>\n\n\n\n- M. Hrubi\u0161ko (Bratislava, SR): \u010co v\u0161etko ovplyv\u0148uje na\u0161e \u00favahy pri
\nvo\u013ebe optim\u00e1lnej lie\u010debnej strat\u00e9gie<\/li> - M. Schvalbov\u00e1 (Pre\u0161ov, SR): Chronoterapia astmy antileukotri\u00e9nmi
\nSymp\u00f3zium podporen\u00e9 spolo\u010dnos\u0165ou Zentiva<\/li><\/ol>\n\n\n\n13.00 \u2013 14.00 IgE \u2013 spolo\u010dn\u00fd menovate\u013e viacer\u00fdch ochoren\u00ed
Predsedn\u00edctvo: P. Pru\u017einec, M. Jese\u0148\u00e1k<\/strong><\/h2>\n\n\n\n- P. Pru\u017einec (Bratislava, SR): Biologick\u00e1 lie\u010dba \u2013 viac ne\u017e jednoduch\u00e1 rovnica?<\/li>
- L. Hochmuth (Bansk\u00e1 Bystrica, SR): Anti-IgE \u2013 spr\u00e1vna vo\u013eba pre astmu a CSU <\/li>
- S. Hadvabov\u00e1 (Kom\u00e1rno, SR): Anti-IgE \u2013 cesta k nov\u00e9mu \u017eivotu<\/li>
- M. Jese\u0148\u00e1k (Martin, SR): \u0164a\u017ek\u00e1 astma v detstve \u2013 mal\u00e1 n\u00e1sobilka?
\nSymp\u00f3zium podporen\u00e9 spolo\u010dnos\u0165ou Novartis Slovakia<\/li><\/ol>\n\n\n\n14,00 \u2013 14,30 1000 pod\u00f4b autoinflam\u00e1cie
Predsedn\u00edctvo: P. Pru\u017einec, M. Jese\u0148\u00e1k<\/strong> <\/h2>\n\n\n\n- M. Jese\u0148\u00e1k (Martin, SR): 1000 pod\u00f4b autoinflam\u00e1cie <\/li><\/ol>\n\n\n\n
Symp\u00f3zium podporen\u00e9 spolo\u010dnos\u0165ou Novartis Slovakia<\/p>\n\n\n\n
14.35 \u2013 15.35 Alergia na rozto\u010de a s \u0148ou spojen\u00e9 komplik\u00e1cie
Predsedn\u00edctvo: M. Hrubi\u0161ko, P. Panzne<\/strong>r <\/h2>\n\n\n\n- P. Ziegelmayer (Viede\u0148, AT): Burden of HDM allergic respiratory diseases<\/li>
- M. Jese\u0148\u00e1k (Martin, SR): Novinky a zvl\u00e1\u0161tnosti rozto\u010dovej alergie
\nSymp\u00f3zium podporen\u00e9 spolo\u010dnos\u0165ou Stallergenes Greer<\/li><\/ol>\n\n\n\n15.40 \u2013 16.40 Aktuality v protil\u00e1tkov\u00fdch deficitoch a poruch\u00e1ch komplementu
Predsedn\u00edctvo: H. Farkas, M. Hrubi\u0161ko, M. Jese\u0148\u00e1k<\/strong><\/h2>\n\n\n\n- H. Farkas (Budape\u0161\u0165, HU): Principles of long term prevention in HAE <\/li>
- M. Jese\u0148\u00e1k (Martin, SR): Lanadelumab \u2013 new option in HAE prevention<\/li>
- M. Hrubi\u0161ko, M. Schvalbov\u00e1 (Bratislava, Pre\u0161ov, SR): Pristupujeme spr\u00e1vne k sekund\u00e1rej imunodeficiencii? Guidelines n\u00e1m pom\u00f4\u017eu.
\nSymp\u00f3zium podporen\u00e9 spolo\u010dnos\u0165ou Takeda<\/li><\/ol>\n\n\n\n16.45 \u2013 18,15 Heredit\u00e1rny angioed\u00e9m \u2013 UpToDate
Predsedn\u00edctvo: H. Farkas, M. Jese\u0148\u00e1k, R. Hakl<\/strong><\/h2>\n\n\n\n- H. Farkas H. (Budape\u0161\u0165, HU): Clinical characteristics and management of HAE in paediatric patients <\/li>
- T. Freiberger et al. (Brno, \u010cR): New forms of hereditary angioedema (Nov\u00e9 formy heredit\u00e1rn\u00edho angioed\u00e9mu) <\/li>
- R. Hakl et al. (Brno, \u010cR): Short-term prophylaxis\/perioperative management of hereditary angioedema (Kr\u00e1tkodob\u00e1 profylaxie\/perioperativn\u00ed management HAE) <\/li>
- M. Jese\u0148\u00e1k et al. (Martin, Bratislava, SR): Strategies and indications for long-term prophylaxis in the management of hereditary angioedema <\/li><\/ol>\n\n\n\n
<\/p>\n<\/div>\n\n\n\n
\n
S\u00e1la B
8,20 \u2013 9,30 Reproduk\u010dn\u00e1 imunol\u00f3gia
Predsedn\u00edctvo: \u017d. Dzurillov\u00e1, Z. Ul\u010dov\u00e1-Gallov\u00e1<\/strong><\/h2>\n\n\n\n- Z. Ul\u010dov\u00e1-Gallov\u00e1 et al. (Plze\u0148, \u010cR): Sledov\u00e1n\u00ed NK bun\u011bk v ovula\u010dn\u00edm cervik\u00e1ln\u00edm sekretu a v endometriu u pacientek opakovan\u011b potr\u00e1cej\u00edc\u00edch<\/li>
- K. Bergendiov\u00e1 et al. (Bratislava, SR):Terapeutick\u00e9 mo\u017enosti pri r\u00f4znych poruch\u00e1ch reprodukcie <\/li>
- M. Le\u0161\u0165an et al. (Pre\u0161ov, SR): Poruchy lekt\u00ednovej cesty aktiv\u00e1cie komplementu z poh\u013eadu reproduk\u010dnej imunol\u00f3gie <\/li>
- \u017d. Dzurillov\u00e1, M. Dzurilla (Nitra, SR): Sledovanie dynamiky T- regula\u010dn\u00fdch lymfocytov v perif\u00e9rnej krvi u tehotn\u00fdch \u017eien s poruchou plodnosti na imunointerven\u010dnej lie\u010dbe <\/li><\/ol>\n\n\n\n
9,35 \u2013 11,00 Alergia na jed blanokr\u00eddleho hmyzu
Predsedn\u00edctvo: I. Hlinka, M. Hrubi\u0161ko<\/strong><\/h2>\n\n\n\n- I. Hlinka (Ke\u017emarok, SR):Bezpe\u010dnos\u0165 alerg\u00e9novej imunoterapie jedom blanokr\u00eddleho hmyzu<\/li>
- M. Hrubi\u0161ko (Bratislava, SR): Boj\u00edme sa lie\u010di\u0165? Bojme sa nelie\u010di\u0165! <\/li>
- J. Petriskov\u00e1, M. Jese\u0148\u00e1k (Martin, SR): Laborat\u00f3rna diagnostika alergie na blanokr\u00eddly hmyz <\/li>
- L. Hochmuth (Bansk\u00e1 Bystrica, SR): \u00daskalia AIT pri alergii na blanokr\u00eddly hmyz<\/li>
- A. Bob\u010d\u00e1kov\u00e1, M. Jese\u0148\u00e1k (Martin, SR): Mastocyt\u00f3za a alergia na blanokr\u00eddly hmyz<\/li>
- T. E\u0161tokov\u00e1 et al. Pre\u0161ov, SR): Praktick\u00e9 sk\u00fasenosti s indik\u00e1ciou AIT pri alergii na jed blanokr\u00eddleho hmyzu<\/li>
- M. Vachov\u00e1 et al. (Plze\u0148, \u010cR): Mastocyt\u00f3za u pacient\u016f s alergi\u00ed na hmyz\u00ed jed (HVA) \u2013 kazuistiky<\/li><\/ol>\n\n\n\n
11,05 \u2013 12,40 Sekcia sestier a laborantov
Predsedn\u00edctvo: J. \u0160imon\u00ed\u010dkov\u00e1, D. Chleb\u00e1kov\u00e1, E. Lap\u0161ansk\u00e1<\/strong><\/h2>\n\n\n\n- E. Ka\u0161\u00e1kov\u00e1,E.(Praha, \u010cR) : Edukace ve spr\u00e1vn\u00e9 inhala\u010dn\u00ed technice-kl\u00ed\u010dov\u00e1 role sestry <\/li>
- M. Macejov\u00e1, B. \u0160v\u00e1bov\u00e1, T. Ku\u017ema (Pre\u0161ov, SR): N\u00e1dej pre alergikov – komponentov\u00e1 diagnostika <\/li>
- \u0160. Dobi\u00e1\u0161ov\u00e1 (Kol\u00edn, \u010cR): Jak testujeme potravinov\u00e9 alergie<\/li>
- M. Paukertov\u00e1 et al. (Kol\u00edn, \u010cR): Jak vy\u0161et\u0159ujeme v Kol\u00edn\u011b<\/li>
- L. Cesnekov\u00e1 (\u0160umperk, \u010cR).: Existuje alergie na pr\u00e1ci?<\/li>
- J. \u0160imon\u00ed\u010dkov\u00e1 (Praha, \u010cR): Nefarmakologick\u00e9 l\u00e9\u010debn\u00e9 postupy v alergologii<\/li>
- D. Chleb\u00e1kov\u00e1, T. Ku\u017ema (Pre\u0161ov, SR): Imunomodul\u00e1cia z poh\u013eadu sestry<\/li>
- N. Hrickov\u00e1 et al. (Pre\u0161ov, SR): Latentn\u00e1 tuberkul\u00f3za a jej diagnostika <\/li><\/ol>\n\n\n\n
13,00 \u2013 14,45 Liekov\u00e1 alergia
Predsedn\u00edctvo: I. Hlinka, B. Novotn\u00e1, A. Smie\u0161kov\u00e1<\/strong><\/h2>\n\n\n\n- M. Smie\u0161ko (Bazilej, \u0160vaj\u010diarsko):Molekulovo-modelovacie simul\u00e1cie interakci\u00ed lie\u010div a cytochr\u00f3mu P450 2D<\/li>
- B. Novotn\u00e1 B.(Brno, \u010cR): Hypersenzitivn\u00ed reakce na n\u00edzkomolekul\u00e1rn\u00ed hepariny<\/li>
- L. Sedl\u00e1\u010dkov\u00e1 et al. (Praha, \u010cR): Detektivka periopera\u010dn\u00ed anafylaxe aneb p\u0159\u00edli\u0161 mnoho podez\u0159el\u00fdch.<\/li>
- I. Hlinka (Ke\u017emarok, SR): Alergia a sulfonamidy <\/li>
- A. Smie\u0161kov\u00e1 (Pre\u0161ov, SR): Alergia na v\u0161etko?<\/li>
- M. Kolej\u00e1kov\u00e1 (Nov\u00e9 Z\u00e1mky, SR): Hypersenzit\u00edvna reakcia na lok\u00e1lne anestetik\u00e1 <\/li><\/ol>\n\n\n\n
14,50 \u2013 16,20 Imunol\u00f3gia v dermatol\u00f3gii
Predsedn\u00edctvo: P. Pru\u017einec, P. Mach\u00e1\u010dek<\/strong><\/h2>\n\n\n\n- P. Mach\u00e1\u010dek P. (Nov\u00fd Ji\u010d\u00edn, \u010cR): Alergie na vonn\u00e9 l\u00e1tky <\/li>
- O. Petrovi\u010dov\u00e1 et al. (Martin, SR): Omalizumab v lie\u010dbe CSU of label u det\u00ed<\/li>
- J. P\u00e9\u010d, K. et al. (Martin, SR): Komplexn\u00fd poh\u013ead na hiidradenitis suppurativa<\/li>
- K. Cajchanov\u00e1 (Bratislava, SR): Psori\u00e1za indukovan\u00e1 interferonom alfa<\/li>
- J. Nem\u0161ovsk\u00e1 (Bratislava, SR): Liekov\u00e1 alergia <\/li><\/ol>\n\n\n\n
16,30 \u2013 18,20 Ak\u00fatne stavy
Predsedn\u00edctvo: J. Mikler, P. Ku\u010dera, V. Petr\u016f<\/strong><\/h2>\n\n\n\n- V. Petr\u016f (Praha, \u010cR): Anafylaxe v Evrop\u011b <\/li>
- J. Mikler et al. (Martin, SR, Nov\u00fd Ji\u010d\u00edn, \u010cR): Anafylaxia v SR a \u010cR<\/li>
- P. Ku\u010dera (Praha, \u010cR): Biomarkery anafylaxe <\/li>
- P. Mach\u00e1\u010dek, J. Mikler (Nov\u00fd Ji\u010d\u00edn, \u010cR, Martin, SR): Medikament\u00f3zn\u00ed mana\u017ement u anafylaxe<\/li>
- L. Kapustov\u00e1 et al. (Martin, SR): Cvi\u010den\u00edm indukovan\u00e1 potravinami asociovan\u00e1 anafylaxia <\/li><\/ol>\n<\/div>\n<\/div>\n\n\n\n
\n\n\n\nPIATOK 4.10.2019<\/h2>\n\n\n\n
\n\n\n\n\n
\n
S\u00c1LA A<\/strong><\/p>\n\n\n\n8,20 \u2013 9,55 Imunol\u00f3gia v gastroenetrol\u00f3gii
Predsedn\u00edctvo: K. Koss\u00e1rov\u00e1, M. Oltman, M. Buc<\/strong><\/h2>\n\n\n\n- \u00davod: K. Koss\u00e1rov\u00e1 (Bratislava, SR): \u010co sp\u00e1ja gastroenterol\u00f3ga a imunol\u00f3ga<\/li>
- M. Oltman (Bratislava, SR): Pe\u010de\u0148 a mikrobiota<\/li>
- M. Buc (Bratislava, SR): \u00daloha ILC- buniek v rozvoji imunologick\u00fdch procesov pri IBD a mo\u017enosti ich ovplyvnenia imunoterapiou <\/li>
- Z. Abaffyov\u00e1, Z. Rennerov\u00e1 (Bratislava, SR): Eozinofilov\u00e9 z\u00e1paly gastrointestin\u00e1lneho traktu, miesto alergo-imunol\u00f3ga v ich mene\u017emente <\/li>
- M. Vran\u00e1, R. Macnerov\u00e1 Praha, \u010cR): Specifick\u00e9 haplotypy HLA jako z\u00e1kladn\u00ed podm\u00ednka rozvoje celiakie <\/li><\/ol>\n\n\n\n
10.00 \u2013 11.00 Eozinofilov\u00e1 astma \u2013 od te\u00f3rie k praxi
Predsedn\u00edctvo: \u0160. La\u0161\u0161\u00e1n, L. Hochmuth<\/strong><\/h2>\n\n\n\n- \u0160. La\u0161\u0161\u00e1n (Bratislava, SR): \u010co n\u00e1m uk\u00e1zali \u0161t\u00fadie <\/li>
- L. Hochmuth (Bansk\u00e1 Bystrica, SR): Ak\u00e1 je realita v ambulancii alergol\u00f3ga<\/li>
- V. Urdov\u00e1 (Bansk\u00e1 Bystrica, SR): Ak\u00e1 je realita v ambulancii pneumol\u00f3ga
\nSymp\u00f3zium podporen\u00e9 spolo\u010dnos\u0165ou GlaxoSmithKline <\/li><\/ol>\n\n\n\n11,05 \u2013 12,05 \u010co n\u00e1s \u010dak\u00e1 za obzorom?
Predsedn\u00edctvo: M. Hrubi\u0161ko, P. Pru\u017einec<\/strong><\/h2>\n\n\n\n- P. Pru\u017einec (Bratislava, SR): Klimatick\u00e9 zmeny a alergia<\/li>
- R. Ko\u0161turiak (Nitra, SR): Senzibiliz\u00e1cia pacientov v regi\u00f3ne Nitry<\/li>
- M. Hrubi\u0161ko (Bratislava, SR): Nov\u00e1 tableta na lie\u010dbu ambr\u00f3ziovej alergie je tu!<\/li>
- M. Jese\u0148\u00e1k (Martin, SR): Nov\u00e1 tableta na lie\u010dbu stromovej alergie
Symp\u00f3zium podporen\u00e9 spolo\u010dnos\u0165ou ALK Slovakia<\/li><\/ol>\n\n\n\n13,00 \u2013 13,45 St\u00e1le aktu\u00e1lne t\u00e9my
Predsedn\u00edctvo: K. Koss\u00e1rov\u00e1, \u0160. La\u0161\u0161\u00e1n<\/strong><\/h2>\n\n\n\n- J. Kyselovi\u010d (Bratislava, SR): S\u00fa\u010dasn\u00fd poh\u013ead na tradi\u010dn\u00fa molekulu z poh\u013eadu farmakol\u00f3ga<\/li>
- B. Matula (Nitra, SR): In\u0161pirovan\u00e9 insp\u00edriom – ale samotn\u00fd n\u00e1dych nesta\u010d\u00ed
Symp\u00f3zium podporen\u00e9 spolo\u010dnos\u0165ou Chiesi Slovakia <\/li><\/ol>\n\n\n\n13,50 \u2013 14,20 Kde sa nach\u00e1dzame v prevencii a managemente detsk\u00fdch alergi\u00ed?
Predsedn\u00edctvo: A. Feketeov\u00e1, J. Mikler <\/strong><\/h2>\n\n\n\n- M. Fuchs (Praha, \u010cR): Poh\u013ead alergol\u00f3ga na prevenciu a lie\u010dbu potravinov\u00fdch alergi\u00ed u det\u00ed<\/li>
- M. Vydra (Praha, \u010cR): Synbiotik\u00e1 v prevencii a managemente detsk\u00fdch alergi\u00ed?
Symp\u00f3zium podporen\u00e9 spolo\u010dnos\u0165ou Nutricia<\/li><\/ol>\n\n\n\n14,35 \u2013 16,50 Asthma bronchiale
Predsedn\u00edctvo: M. Hrubi\u0161ko, P. Pohunek, M. Schvalbov\u00e1<\/strong><\/h2>\n\n\n\n- M. Hrubi\u0161ko (Bratislava, SR): Novinky z GINA 2019, alebo vieme \u010do je a \u010do nie je astma?<\/li>
- V. Ka\u0161\u00e1k (Praha, \u010cR): Inhala\u010dn\u00ed syst\u00e9my zn\u00e1me a nezn\u00e1me<\/li>
- P. Pohunek (Praha, \u010cR): Co p\u0159inesla GINA 2019 d\u011btem s pr\u016fdu\u0161kov\u00fdm astmatem?<\/li>
- R. Ko\u0161turiak (Nitra, SR): Astma – s\u00fa v\u0161etky alerg\u00e9ny rovnak\u00e9?<\/li>
- I. Kr\u010dmov\u00e1 (Hradec Kr\u00e1lov\u00e9, \u010cR): Astma a mikrobiom.<\/li>
- J. Koryt\u00e1rov\u00e1 et al. Pie\u0161\u0165any, Trnava, SR): Astma a obezita a vitam\u00edn D<\/li>
- S. Janota et al. ( Bratislava, Ko\u0161ice, Pie\u0161\u0165any, SR): \u010co tr\u00e1pi na\u0161ich astmatikov? <\/li>
- J. Nov\u00e1k (Praha, \u010cR): SCREENING SYST\u00c9MOV\u00ddCH \u00da\u010cINK\u016e INHALA\u010cN\u00cdCH KORTIKOSTEROID\u016e <\/li><\/ol>\n\n\n\n
16,55\u2013 18,15 Potravinov\u00e1 alergia v pediatrii
Predsedn\u00edctvo: P. \u010ci\u017en\u00e1r, M. Fuchs<\/strong><\/h2>\n\n\n\n- M. Fuchs (Praha, \u010cR): Syndrom FPIES u kojencu a batolat <\/li>
- P. \u010ci\u017en\u00e1r (Bratislava, SR): \u0160tandardn\u00fd diagnostick\u00fd a terapeutick\u00fd postup SSAKI \u2013 alergia na bielkoviny kravsk\u00e9ho mlieka <\/li>
- I. \u0160etinov\u00e1 (Praha, \u010cR): SNAS \u2013 systemic nickel allergy syndrome <\/li>
- Z. Rennerov\u00e1, Z. Vojtu\u0161ov\u00e1, Z. Abaffyov\u00e1 (Bratislava, Pre\u0161ov, SR): Alergia na ara\u0161idy – skuto\u010dne sa n\u00e1s net\u00fdka? <\/li>
- E. Vrbov\u00e1 (Praha, \u010cesko): Potravinov\u00e1 alergie kojeneck\u00e9ho v\u011bku – zn\u00e1m\u00e1 a nezn\u00e1m\u00e1 (kazuistiky) <\/li><\/ol>\n<\/div>\n\n\n\n
\n
S\u00c1LA B<\/strong><\/p>\n\n\n\n8,30 \u2013 10,10 Imunol\u00f3gia infek\u010dn\u00fdch ochoren\u00ed
Predsedn\u00edctvo: M. Jese\u0148\u00e1k, R. Ostr\u00f3 <\/strong><\/h2>\n\n\n\n- M. Jese\u0148\u00e1k (Martin, SR): Tr\u00e9novan\u00e1 imunita a jej v\u00fdznam v anti-infek\u010dnej obrane <\/li>
- P. \u010ci\u017en\u00e1r (Bratislava, SR): Genetick\u00e9 pr\u00ed\u010diny herpetick\u00fdch infekci\u00ed <\/li>
- R. Ostr\u00f3 (Ko\u0161ice, SR): Vroden\u00e1 vn\u00edmavos\u0165 na mykobakt\u00e9riov\u00e9 infekcie a genetick\u00e1 predispoz\u00edcia na tuberkul\u00f3zu<\/li>
- J. Kayserov\u00e1 (Praha, \u010cR): Chronick\u00e1 mukokut\u00e1nna kandid\u00f3za a jej genetick\u00e9 pr\u00ed\u010diny<\/li>
- M. Jese\u0148\u00e1k, P. B\u00e1nov\u010din (Martin, SR): Genetick\u00e9 pr\u00ed\u010diny ne\u017eiaducich reakci\u00ed po \u017eiv\u00fdch atenuovan\u00fdch vakc\u00ednach <\/li>
- R. Ko\u0161turiak (Nitra, SR): Tr\u00e9ning a pam\u00e4\u0165 imunitn\u00e9ho syst\u00e9mu v prevencii infek\u010dn\u00fdch ochoren\u00ed
Predn\u00e1\u0161ka podporen\u00e1 spolo\u010dnos\u0165ou Benela<\/li><\/ol>\n\n\n\n10,15 \u2013 12,00 Imunol\u00f3gia v neurol\u00f3gii
Predsedn\u00edctvo: E. Kl\u00edmov\u00e1, V. Kr\u00e1l, A. Smie\u0161kov\u00e1<\/strong><\/h2>\n\n\n\n- V. Kr\u00e1l (\u00dasti n\/Labem, \u010cR): Imunologick\u00e1 laboratorn\u00ed diagnostika v neurologii <\/li>
- M. Buc (Bratislava, SR): Imunopatogen\u00e9za a imunoterapia neuromyelitis optica <\/li>
- E. Kl\u00edmov\u00e1 (Pre\u0161ov, SR): Spolupr\u00e1ca neurol\u00f3ga a imunol\u00f3ga v zvl\u00e1dnut\u00ed rebound fenom\u00e9nu SM po ukon\u010den\u00ed DMD 2 l\u00ednie pre pl\u00e1novan\u00fa graviditu <\/li>
- M. Serdahelyov\u00e1 (Skalica, SR): Komplik\u00e1cie biologickej lie\u010dby sclerosis multiplex <\/li>
- I. Shawkatov\u00e1 et al. (Bratislava, SR): Nov\u0161ie rizikov\u00e9 varianty v genetickej determin\u00e1cii Alzheimerovej choroby. <\/li><\/ol>\n\n\n\n
13,00 \u2013 13,30 Druh\u00fd typ alergick\u00e9ho z\u00e1palu a modern\u00e9 mo\u017enosti jeho lie\u010dby
Predsedn\u00edctvo: P. Pru\u017einec, M. Jese\u0148\u00e1k<\/strong>
<\/h2>\n\n\n\n- M. Jese\u0148\u00e1k (Martin, SR): Druh\u00fd typ alergick\u00e9ho z\u00e1palu a modern\u00e9 mo\u017enosti jeho lie\u010dby<\/li>
- P. Pru\u017einec (Bratislava, SR): S\u00fa\u010dasn\u00e9 a bud\u00face mo\u017enosti lie\u010dby nekontrolovanej perzistuj\u00facej astmy so z\u00e1palom typu 2
Symp\u00f3zium podporen\u00e9 spolo\u010dnos\u0165ou Sanofi-aventis Pharma Slovakia<\/li><\/ol>\n\n\n\n13,30 \u2013 15,15 Alergol\u00f3gia v postfaktickej dobe
Predsedn\u00edctvo: L. Hochmuth, R. Ko\u0161turiak<\/strong><\/h2>\n\n\n\n- R. Ko\u0161turiak (Nitra, SR): Medic\u00edna v postfaktickej dobe <\/li>
- L. Hochmuth (Bansk\u00e1 Bystrica, SR): Asthma bronchiale: platia diagnostick\u00e9 krit\u00e9ri\u00e1?<\/li>
- P. Pru\u017einec (Bratislava, SR): Je medic\u00edna zalo\u017een\u00e1 na d\u00f4kazoch? <\/li>
- S. Borzov\u00e1, R. Borza (Michalovce, SR): Trpeli na\u0161i predkovia na potravinov\u00fa alergiu? <\/li>
- E. Balkov\u00e1 (Bansk\u00e1 Bystrica, SR): ASTHMA BRONCHIALE (ALERGIA) V SKUTO\u010cNOM \u017dIVOTE \u2013 \u201epresn\u00e1 medic\u00edna\u201c? <\/li>
- S. Janota et al. (Bratislava, Ko\u0161ice, Pie\u0161\u0165any, SR): Adherencia pacientov a zmena preskripcie liekov (anitialerg\u00edk a antiastmat\u00edk) po prv\u00fdch 6 mesiacoch lie\u010dby po indik\u00e1cii rozto\u010dovej tabletovej sublingu\u00e1lnej alerg\u00e9novej imunoterapie (RSLIT) <\/li><\/ol>\n\n\n\n
15,20 \u2013 17,30 Varia
Predsedn\u00edctvo: M. Bucov\u00e1, P. \u010c\u00e1p
Krst knihy:
Petr \u010c\u00e1p: Alergologie do kapsy <\/strong><\/h2>\n\n\n\n- P. \u010c\u00e1p (Praha, \u010cR): Imunita a stres<\/li>
- M. Jese\u0148\u00e1k (Martin, SR): Fytofarmak\u00e1 v mene\u017emente respira\u010dn\u00fdch ochoren\u00ed v kontexte medic\u00edny zalo\u017eenej na d\u00f4kazoch. Predn\u00e1\u0161ka podporen\u00e1 spolo\u010dnos\u0165ou Schwabe Slovakia<\/li>
- J. Bystro\u0148 et al. (Ostrava, \u010cR): Mo\u017enosti multiplexov\u00e9 anal\u00fdzy p\u0159i monitorov\u00e1n\u00ed \u00fa\u010dinnosti sublinqu\u00e1ln\u00ed alergenov\u00e9 imunoterapie. <\/li>
- R. Ko\u0161turiak (Nitra, SR): Antihistaminik\u00e1 2. gener\u00e1cie – update 2019 Predn\u00e1\u0161ka podporen\u00e1 spolo\u010dnos\u0165ou Berlin-Chemie Menarini<\/li>
- M. Bucov\u00e1 et al. (Bratislava, SR): \u00daloha molek\u00fal TREM, HMGB1 a cytok\u00ednov v patogen\u00e9ze gli\u00f3mov <\/li>
- R. Ko\u0161turiak (Nitra, SR): Azoxim\u00e9r bromid a n\u00e1dorov\u00e9 ochorenia – od experimentu ku klinike Predn\u00e1\u0161ka podporen\u00e1 spolo\u010dnos\u0165ou Medigroup<\/li>
- B. Hru\u0161kovi\u010d, \u013d. Sanisl\u00f3 (Bratislava): Histam\u00ednov\u00e1 intolerancia a vitam\u00edn C. Nov\u00e9 poznatky o patofyziol\u00f3gii a iv. lie\u010dbe vitam\u00ednom C. Predn\u00e1\u0161ka podporen\u00e1 spolo\u010dnos\u0165ou Pascoe<\/li><\/ol>\n<\/div>\n<\/div>\n\n\n\n
\n\n\n\nSOBOTA 5.10.2019<\/h2>\n\n\n\n
\n\n\n\n
Postgradu\u00e1lny kurz \u2013 O\u010dkovanie v \u0161peci\u00e1lnych situ\u00e1ci\u00e1ch 9,00 – 13,00<\/strong><\/p>\n\n\n\n- P. Pru\u017einec (Bratislava, SR): Pre\u010do nem\u00e1me o\u010dkova\u0165\u2026<\/li>
- M. Jese\u0148\u00e1k, I. Urban\u010d\u00edkov\u00e1 (Martin, Ko\u0161ice, SR): O\u010dkovanie
\nv \u0161peci\u00e1lnych situ\u00e1ci\u00e1ch a hodnotenie ved\u013eaj\u0161\u00edch pr\u00edhod po o\u010dkovan\u00ed<\/li> - H. Kayserov\u00e1 (Bratislava, SR): S\u00fa\u010dasn\u00fd poh\u013ead na o\u010dkovanie proti
\ntuberkul\u00f3ze<\/li> - Z. Rennerov\u00e1 (Bratislava, SR): Potravinov\u00e1 alergia a o\u010dkovanie<\/li>
- Z. Abaffyov\u00e1 (Bratislava, SR): Alergick\u00e9 reakcie po o\u010dkovan\u00ed a ich
\nmana\u017ement <\/li> - A. Smie\u0161kov\u00e1 (Pre\u0161ov, SR): Alergia na antibiotik\u00e1 a o\u010dkovanie<\/li>
- K. Koss\u00e1rov\u00e1 (Bratislava, SR): O\u010dkovanie a chronick\u00e9 respira\u010dn\u00e9
\nochorenia<\/li> - M. Schvalbov\u00e1 (Pre\u0161ov, SR): O\u010dkovanie zdravotn\u00edkov<\/li>
- P. \u010ci\u017en\u00e1r (Bratislava, SR): O\u010dkovanie a imunodeficiencie<\/li>
- L. Hochmuth (Bansk\u00e1 Bystrica, SR): O\u010dkovanie a sclerosis multiplex<\/li>
- M. Jese\u0148\u00e1k (Martin, SR): O\u010dkovanie a autoimunitn\u00e9 ochorenia<\/li>
- M. Hrubi\u0161ko (Bratislava, SR): O\u010dkovanie onkologick\u00fdch pacientov<\/li>
- M. Jese\u0148\u00e1k (Martin, SR): Z\u00e1ver kurzu<\/li><\/ol>\n\n\n\n
\n\n\n\nPosterov\u00e1 sekcia<\/h2>\n\n\n\n
Varia<\/strong>
J. Laff\u00e9rsov\u00e1, L. Hochmuth, Z. Snopkov\u00e1 (Bansk\u00e1 Bystrica): Pe\u013eov\u00e1 informa\u010dn\u00e1 slu\u017eba: pe\u013eov\u00e1 sez\u00f3na 2019 na Slovensku
A. Lochmanov\u00e1, I. Lochman, J. Martinek (Ostrava, \u010cR): Vliv kultiva\u010dn\u00edho prost\u0159ed\u00ed na funk\u010dn\u00ed aktivitu lymfocyt\u016f<\/p>\n\n\n\nE. Vrbov\u00e1, M. Fuchs (Praha, \u010cR): Flykt\u00e9nov\u00e1 keratokonjunktivitida<\/p>\n\n\n\n
E. Koukalov\u00e1, B. Hutyrov\u00e1 (Olomouc, \u010cR): Du\u0161nost u astmatika – jen zhor\u0161en\u00e9 astma? <\/p>\n\n\n\n
I. Kr\u00e1lov\u00e1 Lesn\u00e1, S. \u010cejkov\u00e1, H. Kubatov\u00e1, M. Fialov\u00e1., J. Fronek., L. Janou\u0161ek, R. Poledne (Praha, \u010cR): Macrophage polarization in human adipose tissue and its relationship to cardiovascular risk factors<\/p>\n\n\n\n
F. Mr\u00e1zek, J. Luke\u0161, A. Petr\u00e1\u010dkov\u00e1, A. Smr\u017eov\u00e1, M. Schubertov\u00e1, M. Sk\u00e1celov\u00e1, G. Gab\u010dov\u00e1, E. Kriegov\u00e1, P. Hor\u00e1k (Olomouc, \u010cR): S\u00e9rov\u00fd profil asymetrick\u00e9ho dimethylargininu u pacient\u016f se syst\u00e9mov\u00fdm lupus erythematodes a sklerodermi\u00ed<\/p>\n\n\n\n
Z. P\u00e1rnick\u00e1, J. Javor, V. \u010eurmanov\u00e1, V. Budinsk\u00e1, M. Kr\u00e1lov\u00e1, J. Pe\u010de\u0148\u00e1k, B. Va\u0161e\u010dkov\u00e1, V. Re\u017en\u00e1kov\u00e1, K. Gmitterov\u00e1, T. Hrom\u00e1dka, I. Shawkatov\u00e1 (Bratislava, SR): Anal\u00fdza anamnestick\u00fdch d\u00e1t a testu MoCA v r\u00e1mci imunogenetickej \u0161t\u00fadie Alzheimerovej choroby (predbe\u017en\u00e9 v\u00fdsledky)<\/p>\n\n\n\n
M. Such\u00e1nkov\u00e1, J. Urban, M. G\u00e1novsk\u00e1, E. Tibensk\u00e1, K. Szaboov\u00e1, E. Tedlov\u00e1, I. Majer, M. Bobov\u010d\u00e1k, I. Jonner, M. Bucov\u00e1 (Bratislava, Vy\u0161n\u00e9 H\u00e1gy, SR): Expresie receptorov TREM-1 a TREM-2 na povrchu alveol\u00e1rnych makrof\u00e1gov v kontexte T bunkovej imunitnej odpovede pri p\u013e\u00facnej sarkoid\u00f3ze a hypersenzit\u00edvnej pneumonit\u00edde
\nJ. Urban, M. Such\u00e1nkov\u00e1, M. G\u00e1novsk\u00e1, I. Jonner, M. Bucov\u00e1 (Vy\u0161n\u00e9 H\u00e1gy, Bratislava, SR): Anal\u00fdza CX3CL1 ako mo\u017en\u00e9ho markera fibrotiz\u00e1cie u vybran\u00fdch dif\u00faznych parench\u00fdmov\u00fdch p\u013e\u00facnych procesov<\/p>\n\n\n\n
J. Martinek, A. Lochmanov\u00e1, A. Kloudov\u00e1, J. Motlochov\u00e1, H. Da\u0159\u00ed\u010dkov\u00e1, V. Nov\u00e1k (Ostrava, \u010cR): Nov\u00fd algoritmus vy\u0161et\u0159ov\u00e1n\u00ed autoprotil\u00e1tek u ANCA asociovan\u00fdch vaskulitid<\/p>\n\n\n\n
M. Homolov\u00e1, E. Bojt\u00e1rov\u00e1, M. Kov\u00e1\u010dov\u00e1, K. K\u013eu\u010dkov\u00e1, I. Waczul\u00edkov\u00e1, M. Ku\u0161\u00edkov\u00e1 , M. Mistr\u00edk , I. Shawkatov\u00e1 (Bratislava, SR): Vplyv HLA-aliel na vznik ak\u00fatnej a chronickej GVHD po alog\u00e9nnej transplant\u00e1cii krvotvorn\u00fdch buniek <\/p>\n\n\n\n
D. Kant\u00e1rov\u00e1, I. Peron\u010d\u00edkov\u00e1, N. M\u00e4\u010dkov\u00e1, I. S\u00e1gov\u00e1, M. Vrl\u00edk (Martin, SR): Vplyv bakteriof\u00e1gov na imunitn\u00fd syst\u00e9m<\/p>\n\n\n\n
Imunol\u00f3gia v gastroenetrol\u00f3gii <\/strong>
N. Galanov\u00e1, L. Bajer, M. Kostov\u010d\u00edk, M. Kola\u0159\u00edk, M. Kverka, K. Kostov\u010d\u00edkov\u00e1 (Praha, \u010cR): Imunitn\u00ed odpov\u011b\u010f na stimulaci fung\u00e1ln\u00edmi antigeny in vitro <\/p>\n\n\n\n\u0160. Coufal, Z. Jir\u00e1skov\u00e1 Z\u00e1kostelsk\u00e1, F. Rob, J. Hercogov\u00e1, L. Bajer, P. Drastich, M. Kverka (Praha, \u010cR): Pacienti s nespecifick\u00fdmi st\u0159evn\u00edmi z\u00e1n\u011bty b\u011bhem l\u00e9\u010dby inhibitory TNF-\u03b1 maj\u00ed zv\u00fd\u0161en\u00e9 hladiny matrixov\u00fdch metaloprotein\u00e1z 14 a 9 <\/p>\n\n\n\n
\u0160. Coufal, N. Galanov\u00e1, L. Bajer, P. Drastich, H. Tlaskalov\u00e1-Hogenov\u00e1, Z. Jir\u00e1skov\u00e1 Z\u00e1kostelsk\u00e1, M. Kverka (Praha, \u010cR): Biomarkery kostn\u00edho metabolismu, st\u0159evn\u00ed bari\u00e9ry a imunitn\u00ed odpov\u011bdi jsou asociov\u00e1ny s formou a l\u00e9\u010dbou idiopatick\u00fdch st\u0159evn\u00edch z\u00e1n\u011bt\u016f<\/p>\n\n\n\n
B. Pavl\u00edkov\u00e1, A. Hanzelkov\u00e1, H. Hude\u010dkov\u00e1, A. Ondrejkov\u00e1 (Nov\u00fd Ji\u010d\u00edn, \u010cR): Na\u0161e prvn\u00ed zku\u0161enosti s nov\u00fdm funk\u010dn\u00edm testem pro diagnostiku histaminov\u00e9 intolerance ve srovn\u00e1n\u00ed s koncentrac\u00ed diaminooxid\u00e1zy v s\u00e9ru<\/p>\n\n\n\n
Imunodeficiencie<\/strong>
T. Milota, P. Kral\u00ed\u010dkov\u00e1, A. \u0160ediv\u00e1 (Praha, Hradec Kr\u00e1lov\u00e9, \u010cR): N\u00e1dory asociovan\u00e9 s CVID \u2013 \u010desk\u00e1 n\u00e1rodn\u00ed studie zam\u011b\u0159en\u00e1 na epidemiologii, imunologii a genetick\u00e9 pozad\u00ed<\/p>\n\n\n\nK. Roubalov\u00e1, J. Kry\u0161tofov\u00e1, P. Hainz, \u0160. N\u011bme\u010dkov\u00e1 (Praha, \u010cR): Imunodominance antigen\u016f CMV p\u0159i expanzi multivirov\u00fdch virus- specifick\u00fdch T-bun\u011b\u010dn\u00fdch lini\u00ed<\/p>\n\n\n\n
K. Roubalov\u00e1, V. Kr\u00e1l, J. L\u00e1baj, J. Poho\u0159sk\u00e1, A. Lochmanov\u00e1, K. Kut\u011bjov\u00e1, P. Miku\u0161ov\u00e1, J. Furkov\u00e1, Z. \u010cerm\u00e1kov\u00e1, V. Nov\u00e1k, A. Zjev\u00edkov\u00e1, D. J\u00edlek, O. \u017dlabov\u00e1, I. Lochman (Ostrava, Praha, \u00dast\u00ed nad Labem, Vestec, \u010cR): BI-VIDITEST Total, r.t.u. v posuzov\u00e1n\u00ed stavu bun\u011b\u010dn\u00e9 imunity<\/p>\n\n\n\n
Imunol\u00f3gia v neurol\u00f3gii<\/strong>
V. \u010eurmanov\u00e1, J. Javor, Z. P\u00e1rnick\u00e1, T. Hrom\u00e1dka, G. Min\u00e1rik, V. Re\u017en\u00e1kov\u00e1, B. Va\u0161e\u010dkov\u00e1, \u013d. Peterajov\u00e1, I. Shawkatov\u00e1 (Bratislava, SR): Asoci\u00e1cia polymorfizmu MMP3 rs3025058 s klinick\u00fdmi prejavmi Alzheimerovej choroby<\/p>\n\n\n\nJ. Javor, Z. P\u00e1rnick\u00e1, V. \u010eurmanov\u00e1, M. Kr\u00e1lov\u00e1, J. Pe\u010de\u0148\u00e1k, B. Va\u0161e\u010dkov\u00e1, V. Re\u017en\u00e1kov\u00e1, S. \u0160utovsk\u00fd, K. Gmitterov\u00e1, I. Shawkatov\u00e1 (Bratislava, SR)
\nAsoci\u00e1cia polymorfizmu rs11136000 v g\u00e9ne pre kluster\u00edn s rizikom vzniku Alzheimerovej choroby v slovenskej popul\u00e1cii<\/p>\n\n\n\n
Asthma bronchiale<\/strong><\/p>\n\n\n\nF. Kop\u0159iva, J. V\u00e1clavkov\u00e1, T. Gvozdiakov\u00e1, P. D\u017eub\u00e1k, V. L\u00e1talov\u00e1 (Olomouc, \u010cR): Je stanoven\u00ed protein\u016f v kondenz\u00e1tu vydechovan\u00e9ho vzduchu dal\u0161\u00ed cestou k monitorov\u00e1n\u00ed tajupln\u00e9ho z\u00e1n\u011btu u astma bronchiale ?<\/p>\n\n\n\n
K. \u010cer\u0148anov\u00e1, V. L\u00e1talov\u00e1, F. Kop\u0159iva (Olomouc, \u010cR): Vyu\u017eit\u00ed o\u010di\u0161\u0165ovac\u00edho indexu plic (LCI) k diagnostice a managementu rozd\u00edln\u00fdch fenotyp\u016f astma bronchiale \u2013 kazuistika 16. let\u00e9ho astmatika s podez\u0159en\u00edm na syndrom p\u0159ekryvu astma bronchiale a chronick\u00e9 obstruk\u010dn\u00ed plicn\u00ed nemoci (ACOS)<\/p>\n\n\n\n
Imunol\u00f3gia infek\u010dn\u00edch ochoren\u00ed<\/strong><\/p>\n\n\n\n\u0160. N\u011bme\u010dkov\u00e1, E. Ham\u0161\u00edkov\u00e1, P. Hainz, J Kry\u0161tofov\u00e1, V. Ludv\u00edkov\u00e1, J. Musil ( Praha, \u010cR): Anal\u00fdza specifick\u00fdch protil\u00e1tek a odpov\u011bdi T bun\u011bk proti antigen\u016fm BK polyomavirus u pacient\u016f po transplantaci krvetvorn\u00fdch bun\u011bk<\/p>\n\n\n\n
Reproduk\u010dn\u00e1 imunol\u00f3gia<\/strong><\/p>\n\n\n\nH. Kop\u0159ivov\u00e1, R. Musilov\u00e1, K. Mal\u00ed\u010dkov\u00e1, M. Kouck\u00fd (Praha, \u010cR): Zastoupen\u00ed subpopulac\u00ed T regula\u010dn\u00edch lymfocyt\u016f u p\u0159ed\u010dasn\u011b spont\u00e1nn\u011b rod\u00edc\u00edch \u017een <\/p>\n\n\n\n
Alergia na jed blanokr\u00eddleho hmyzu<\/strong>
P. Kr\u00e1lov\u00e1, P. Ku\u010dera, T. Koz\u00e1k (Praha, \u010cR): Prim\u00e1rn\u00ed a sekund\u00e1rn\u00ed mastocyt\u00e1rn\u00ed onemocn\u011bn\u00ed, potencion\u00e1ln\u00ed biomarkery<\/p>\n\r\n","protected":false},"excerpt":{"rendered":"\u0160TVRTOK PIATOK SOBOTA POSTRE STREDA 2.10.2019 15,00 \u2013 15,30 Sl\u00e1vnostn\u00e9 otvorenie Sl\u00e1vnostn\u00e9 uvedenie novej knihy do \u017eivota: O\u010dkovanie v \u0161peci\u00e1lnych situ\u00e1ci\u00e1ch od autorsk\u00e9ho kolekt\u00edvu Milo\u0161 Jese\u0148\u00e1k, Ingrid Urban\u010d\u00edkov\u00e1 a kol. pod z\u00e1\u0161titou SSAKI a...<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-3388189","page","type-page","status-publish","hentry"],"yoast_head":"\n
Program XXXVI. zjazdu SSAKI a \u010cSAKI - Slovensk\u00e1 spolo\u010dnos\u0165 alergol\u00f3gie a klinickej imunol\u00f3gie<\/title>\n<meta name=\"description\" content=\"Sme odborn\u00e1 splo\u010dnos\u0165, ktor\u00e1 zdru\u017euje klinick\u00fdch imunol\u00f3gov a alergol\u00f3gov, ako aj in\u00fdch odborn\u00edkov so z\u00e1ujmom o tento odbor. Na\u0161a spolo\u010dnos\u0165 je hlavn\u00fdm organiz\u00e1torom kontunu\u00e1lneho vzdel\u00e1vania v tomto odbore na Slovensku.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ssaki.eu\/?page_id=3388189\" \/>\n<meta property=\"og:locale\" content=\"sk_SK\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Program XXXVI. zjazdu SSAKI a \u010cSAKI - Slovensk\u00e1 spolo\u010dnos\u0165 alergol\u00f3gie a klinickej imunol\u00f3gie\" \/>\n<meta property=\"og:description\" content=\"Sme odborn\u00e1 splo\u010dnos\u0165, ktor\u00e1 zdru\u017euje klinick\u00fdch imunol\u00f3gov a alergol\u00f3gov, ako aj in\u00fdch odborn\u00edkov so z\u00e1ujmom o tento odbor. Na\u0161a spolo\u010dnos\u0165 je hlavn\u00fdm organiz\u00e1torom kontunu\u00e1lneho vzdel\u00e1vania v tomto odbore na Slovensku.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ssaki.eu\/?page_id=3388189\" \/>\n<meta property=\"og:site_name\" content=\"Slovensk\u00e1 spolo\u010dnos\u0165 alergol\u00f3gie a klinickej imunol\u00f3gie\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/alergologoviaimunologoviaSK\" \/>\n<meta property=\"article:modified_time\" content=\"2019-09-26T21:30:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.ssaki.eu\/wp-content\/uploads\/2021\/01\/STOP_COVID_SSAKI-e1609772027682.png\" \/>\n\t<meta property=\"og:image:width\" content=\"640\" \/>\n\t<meta property=\"og:image:height\" content=\"360\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Predpokladan\u00fd \u010das \u010d\u00edtania\" \/>\n\t<meta name=\"twitter:data1\" content=\"17 min\u00fat\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":[\"WebPage\",\"MedicalWebPage\"],\"@id\":\"https:\\\/\\\/www.ssaki.eu\\\/?page_id=3388189\",\"url\":\"https:\\\/\\\/www.ssaki.eu\\\/?page_id=3388189\",\"name\":\"Program XXXVI. zjazdu SSAKI a \u010cSAKI - Slovensk\u00e1 spolo\u010dnos\u0165 alergol\u00f3gie a klinickej imunol\u00f3gie\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ssaki.eu\\\/#website\"},\"datePublished\":\"2019-08-23T15:23:09+00:00\",\"dateModified\":\"2019-09-26T21:30:52+00:00\",\"description\":\"Sme odborn\u00e1 splo\u010dnos\u0165, ktor\u00e1 zdru\u017euje klinick\u00fdch imunol\u00f3gov a alergol\u00f3gov, ako aj in\u00fdch odborn\u00edkov so z\u00e1ujmom o tento odbor. Na\u0161a spolo\u010dnos\u0165 je hlavn\u00fdm organiz\u00e1torom kontunu\u00e1lneho vzdel\u00e1vania v tomto odbore na Slovensku.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.ssaki.eu\\\/?page_id=3388189#breadcrumb\"},\"inLanguage\":\"sk-SK\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.ssaki.eu\\\/?page_id=3388189\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.ssaki.eu\\\/?page_id=3388189#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Domovsk\u00e1 str\u00e1nka\",\"item\":\"https:\\\/\\\/www.ssaki.eu\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Program XXXVI. zjazdu SSAKI a \u010cSAKI\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.ssaki.eu\\\/#website\",\"url\":\"https:\\\/\\\/www.ssaki.eu\\\/\",\"name\":\"Slovensk\u00e1 spolo\u010dnos\u0165 alergol\u00f3gie a klinickej imunol\u00f3gie\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.ssaki.eu\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.ssaki.eu\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sk-SK\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.ssaki.eu\\\/#organization\",\"name\":\"Slovensk\u00e1 spolo\u010dnos\u0165 alergol\u00f3gie a klinickej imunol\u00f3gie\",\"url\":\"https:\\\/\\\/www.ssaki.eu\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sk-SK\",\"@id\":\"https:\\\/\\\/www.ssaki.eu\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.ssaki.eu\\\/wp-content\\\/uploads\\\/2021\\\/01\\\/LOGO-1.png\",\"contentUrl\":\"https:\\\/\\\/www.ssaki.eu\\\/wp-content\\\/uploads\\\/2021\\\/01\\\/LOGO-1.png\",\"width\":1280,\"height\":720,\"caption\":\"Slovensk\u00e1 spolo\u010dnos\u0165 alergol\u00f3gie a klinickej imunol\u00f3gie\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ssaki.eu\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/alergologoviaimunologoviaSK\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Program XXXVI. zjazdu SSAKI a \u010cSAKI - Slovensk\u00e1 spolo\u010dnos\u0165 alergol\u00f3gie a klinickej imunol\u00f3gie","description":"Sme odborn\u00e1 splo\u010dnos\u0165, ktor\u00e1 zdru\u017euje klinick\u00fdch imunol\u00f3gov a alergol\u00f3gov, ako aj in\u00fdch odborn\u00edkov so z\u00e1ujmom o tento odbor. Na\u0161a spolo\u010dnos\u0165 je hlavn\u00fdm organiz\u00e1torom kontunu\u00e1lneho vzdel\u00e1vania v tomto odbore na Slovensku.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ssaki.eu\/?page_id=3388189","og_locale":"sk_SK","og_type":"article","og_title":"Program XXXVI. zjazdu SSAKI a \u010cSAKI - Slovensk\u00e1 spolo\u010dnos\u0165 alergol\u00f3gie a klinickej imunol\u00f3gie","og_description":"Sme odborn\u00e1 splo\u010dnos\u0165, ktor\u00e1 zdru\u017euje klinick\u00fdch imunol\u00f3gov a alergol\u00f3gov, ako aj in\u00fdch odborn\u00edkov so z\u00e1ujmom o tento odbor. Na\u0161a spolo\u010dnos\u0165 je hlavn\u00fdm organiz\u00e1torom kontunu\u00e1lneho vzdel\u00e1vania v tomto odbore na Slovensku.","og_url":"https:\/\/www.ssaki.eu\/?page_id=3388189","og_site_name":"Slovensk\u00e1 spolo\u010dnos\u0165 alergol\u00f3gie a klinickej imunol\u00f3gie","article_publisher":"https:\/\/www.facebook.com\/alergologoviaimunologoviaSK","article_modified_time":"2019-09-26T21:30:52+00:00","og_image":[{"width":640,"height":360,"url":"https:\/\/www.ssaki.eu\/wp-content\/uploads\/2021\/01\/STOP_COVID_SSAKI-e1609772027682.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Predpokladan\u00fd \u010das \u010d\u00edtania":"17 min\u00fat"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":["WebPage","MedicalWebPage"],"@id":"https:\/\/www.ssaki.eu\/?page_id=3388189","url":"https:\/\/www.ssaki.eu\/?page_id=3388189","name":"Program XXXVI. zjazdu SSAKI a \u010cSAKI - Slovensk\u00e1 spolo\u010dnos\u0165 alergol\u00f3gie a klinickej imunol\u00f3gie","isPartOf":{"@id":"https:\/\/www.ssaki.eu\/#website"},"datePublished":"2019-08-23T15:23:09+00:00","dateModified":"2019-09-26T21:30:52+00:00","description":"Sme odborn\u00e1 splo\u010dnos\u0165, ktor\u00e1 zdru\u017euje klinick\u00fdch imunol\u00f3gov a alergol\u00f3gov, ako aj in\u00fdch odborn\u00edkov so z\u00e1ujmom o tento odbor. Na\u0161a spolo\u010dnos\u0165 je hlavn\u00fdm organiz\u00e1torom kontunu\u00e1lneho vzdel\u00e1vania v tomto odbore na Slovensku.","breadcrumb":{"@id":"https:\/\/www.ssaki.eu\/?page_id=3388189#breadcrumb"},"inLanguage":"sk-SK","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ssaki.eu\/?page_id=3388189"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.ssaki.eu\/?page_id=3388189#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Domovsk\u00e1 str\u00e1nka","item":"https:\/\/www.ssaki.eu\/"},{"@type":"ListItem","position":2,"name":"Program XXXVI. zjazdu SSAKI a \u010cSAKI"}]},{"@type":"WebSite","@id":"https:\/\/www.ssaki.eu\/#website","url":"https:\/\/www.ssaki.eu\/","name":"Slovensk\u00e1 spolo\u010dnos\u0165 alergol\u00f3gie a klinickej imunol\u00f3gie","description":"","publisher":{"@id":"https:\/\/www.ssaki.eu\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ssaki.eu\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sk-SK"},{"@type":"Organization","@id":"https:\/\/www.ssaki.eu\/#organization","name":"Slovensk\u00e1 spolo\u010dnos\u0165 alergol\u00f3gie a klinickej imunol\u00f3gie","url":"https:\/\/www.ssaki.eu\/","logo":{"@type":"ImageObject","inLanguage":"sk-SK","@id":"https:\/\/www.ssaki.eu\/#\/schema\/logo\/image\/","url":"https:\/\/www.ssaki.eu\/wp-content\/uploads\/2021\/01\/LOGO-1.png","contentUrl":"https:\/\/www.ssaki.eu\/wp-content\/uploads\/2021\/01\/LOGO-1.png","width":1280,"height":720,"caption":"Slovensk\u00e1 spolo\u010dnos\u0165 alergol\u00f3gie a klinickej imunol\u00f3gie"},"image":{"@id":"https:\/\/www.ssaki.eu\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/alergologoviaimunologoviaSK"]}]}},"_links":{"self":[{"href":"https:\/\/www.ssaki.eu\/index.php?rest_route=\/wp\/v2\/pages\/3388189","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ssaki.eu\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.ssaki.eu\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.ssaki.eu\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ssaki.eu\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3388189"}],"version-history":[{"count":44,"href":"https:\/\/www.ssaki.eu\/index.php?rest_route=\/wp\/v2\/pages\/3388189\/revisions"}],"predecessor-version":[{"id":3445349,"href":"https:\/\/www.ssaki.eu\/index.php?rest_route=\/wp\/v2\/pages\/3388189\/revisions\/3445349"}],"wp:attachment":[{"href":"https:\/\/www.ssaki.eu\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3388189"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}